Health Care & Life Sciences » Biotechnology | Loxo Oncology Inc.

Loxo Oncology Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
14,994.00
106,292.00
153,892.00
139,311.00
626,200.00
Total Accounts Receivable
-
-
-
-
150,000.00
Other Current Assets
17.00
1,484.00
2,752.00
2,483.00
5,607.00
Total Current Assets
15,011.00
107,776.00
156,644.00
141,794.00
781,807.00
Net Property, Plant & Equipment
-
12.00
88.00
248.00
912.00
Total Investments and Advances
-
6,648.00
300.00
2,799.00
300.00
Other Assets
11.00
23.00
426.00
471.00
423.00
Total Assets
15,022.00
114,459.00
157,458.00
145,312.00
783,442.00
Accounts Payable
221.00
-
-
-
3,996.00
Other Current Liabilities
189.00
1,787.00
2,853.00
15,144.00
217,574.00
Total Current Liabilities
410.00
1,787.00
2,853.00
15,144.00
221,570.00
Other Liabilities
-
-
-
-
183,662.00
Total Liabilities
410.00
1,787.00
2,853.00
15,144.00
405,232.00
Common Equity (Total)
10,231.00
112,672.00
154,605.00
130,168.00
378,210.00
Total Shareholders' Equity
14,612.00
112,672.00
154,605.00
130,168.00
378,210.00
Total Equity
14,612.00
112,672.00
154,605.00
130,168.00
378,210.00
Liabilities & Shareholders' Equity
15,022.00
114,459.00
157,458.00
145,312.00
783,442.00
Preferred Stock (Carrying Value)
24,843.00
-
-
-
-

About Loxo Oncology

View Profile
Address
281 Tresser Boulevard
Stamford Connecticut 06901
United States
Employees -
Website http://www.loxooncology.com
Updated 09/14/2018
Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H.